Clinical Trials

30 enrolled

Multiple Myeloma

NCT00550277 2021-11-23

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

20 enrolled 7 charts

Genitourinary

Carcinoma, Renal Cell

NCT01965353 2021-09-05

PanRVD

21 enrolled

Multiple Myeloma

NCT00936611 2021-01-28

LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia

39 enrolled 13 charts

Waldenstrom Macroglobulinemia, Recurrence

NCT01169636 2021-01-06

Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma

62 enrolled 13 charts

Hodgkin Disease

NCT00918333 2020-03-10

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

DermatologicLymphoidOther hematologic neoplasmPlasma cell

124 enrolled 10 charts

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT02057640 2019-12-11

MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma

16 enrolled 12 charts

Multiple Myeloma

NCT01013597 2019-11-29

Trial of LBH589 in Metastatic Thyroid Cancer

13 enrolled 11 charts

Head & Neck

Thyroid Diseases, Thyroid Neoplasms

NCT01523834 2019-11-22

FIL_PanAL10

35 enrolled 10 charts

Lymphoma, Large B-Cell, Diffuse

NCT01463046 2019-04-22

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Other hematologic neoplasm

29 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT01440582 2019-03-04

Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients

77 enrolled

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01549431 2019-01-16

Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma

32 enrolled

Multiple Myeloma

NCT00840346 2018-12-11

PANOBIDARA

Other hematologic neoplasm

46 enrolled

Leukemia, Myeloid, Acute

NCT01651039 2018-04-09

Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM)

32 enrolled 21 charts

Multiple Myeloma

NCT01336842 2018-01-09

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors

23 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01460940 2017-11-14

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

24 enrolled 7 charts

Hodgkin Disease

NCT01105312 2017-06-27

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

28 enrolled 13 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00878904 2017-03-24

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

40 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00859222 2017-03-14

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

51 enrolled 18 charts

CNS

Glioma

NCT01005797 2017-03-03

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

GenitourinarySarcomaThoracic

38 enrolled

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Sarcoma

NCT00691938 2016-10-13

LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)

MyeloidOther hematologic neoplasm

52 enrolled 18 charts

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01321346 2015-11-24

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

LymphoidOther hematologic neoplasm

30 enrolled

Hodgkin Disease, Leukemia, Leukemia, Myeloid, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00632489 2015-06-08

LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients

20 enrolled 5 charts

Breast

Breast Neoplasms, Neoplasms

NCT00967044 2015-02-26

Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma

31 enrolled 6 charts

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Recurrence

NCT00738751 2015-02-04

Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers

44 enrolled

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT01504776 2014-09-19

BUS48T

3 enrolled

Lymphoma, Lymphoma, Mantle-Cell

NCT00686218 2014-08-15

Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia

Other hematologic neoplasm

9 enrolled

Leukemia, Leukemia, Myeloid, Chronic-Phase

NCT00901147 2014-06-27

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

25 enrolled

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT01136499 2013-03-06

ESTIM-LBH

53 enrolled

Sarcoma

NCT00962507 2013-02-15

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma